# Lorcaserin Intra Venous Cocaine Effects

> **NCT02680288** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Midwest Biomedical Research Foundation** · enrollment: 32 (estimated)

## Conditions studied

- Cocaine Use Disorders

## Interventions

- **DRUG:** Lorcaserin, 10 mg
- **DRUG:** Lorcaserin, 20 mg
- **OTHER:** Oral Placebo

## Key facts

- **NCT ID:** NCT02680288
- **Lead sponsor:** Midwest Biomedical Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2018-09
- **Final completion:** 2019-11
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2016-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02680288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02680288, "Lorcaserin Intra Venous Cocaine Effects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02680288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*